Effect of eight weeks DNS exercises quality of life and function in women with multiple sclerosis

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 440

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

MSC16_027

تاریخ نمایه سازی: 11 آذر 1398

Abstract:

Background: DNS exercises cause stimulating the afresh developmental process of motor nervous system, especially for people with movement problems caused by nervous system s disease through actuating neurodevelopmental locomotor chains based on motor positions of a healthy newborn. Methods: Current study intends to survey this exercise’s effect on 30 women with 0-5.5 EDSS and from 23 to 58 years old. In this research for probing the quality of life factors we used the quality of life questionnaire (MSQOL-54) and for the study of physical function like endurance walking the 6 minutes walking test and as of walking pace the 10 meter ling test was used. Results: Our test results showed t-independent and Mann-Whitney which showed that after 8 weeks of DNS exercises the average of overall quality of life between the control and experimental groups (p=0/001) and their average pace and endurance between the control and experimental groups (p=0/000) is significant difference (α≤0/05). Conclusion: So in conclusion the 8 weeks period of DNS exercises resulted in the quality of life factors, pace and endurance in walking and can be used as a remedial method in quality of life and physical function improvement.

Authors

Sima Zamani

MS. C in sport injuries and corrective exercise, Islamic Azad University, Karaj, Alborz, Iran.

Behnaz Gnaji

Ph. D, department of health and sport medicine, school of physical education, Islamic Azad University, Karaj, Alborz, Iran.

Saeed Shahbeigi

Neurologist and Neuroimmunology Fellow Brain Mapping Research center Shahbid Beheshti Medical University, Neuroscience Research Center Iran Medical University, The chairman of Cell, Gene and Therapy Journal